{"gene":"NOTCH2","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1992,"finding":"NOTCH2 encodes a second mammalian Notch receptor containing all structural motifs characteristic of Notch proteins (EGF-like repeats, transmembrane domain, ankyrin repeats), establishing it as a paralog of Drosophila Notch with distinct spatial and temporal expression patterns from Notch1.","method":"cDNA cloning, Northern blot, in situ hybridization","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — structural identification by cloning with expression profiling; single lab but multiple methods establishing identity and non-redundancy with Notch1","pmids":["1295745"],"is_preprint":false},{"year":1999,"finding":"The ankyrin repeats in the cytoplasmic domain of Notch2 are indispensable for its function; mice homozygous for a Notch2 mutation replacing ankyrin repeats die before E11.5 with increased apoptosis in neural tissues, while somitogenesis and neurogenic gene regulation (Hes-5, Mash1) are unaffected, distinguishing Notch2 from Notch1 functionally.","method":"Gene targeting (knock-in of beta-galactosidase replacing ankyrin repeats), X-gal staining, in situ hybridization, TUNEL assay","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic loss-of-function with precise domain disruption, multiple phenotypic readouts, comparison to Notch1 knockout in same study","pmids":["10393120"],"is_preprint":false},{"year":2002,"finding":"The intracellular domains of Notch1, Notch2, and Notch3 have distinct and non-equivalent transcriptional activities on HES1 and HES5 promoters; Notch2 ICD can suppress the transcriptional activities of Notch1 and Notch3 ICDs in a dose-dependent and promoter-dependent manner, and activity depends on RBP-Jκ expression levels.","method":"Luciferase reporter assay using HES1-Luc and HES5-Luc constructs, transfection of truncated ICD forms, co-expression experiments","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro transcriptional assays with defined constructs; single lab, single method type","pmids":["11866432"],"is_preprint":false},{"year":2006,"finding":"Constitutively activated Notch2 in pre-gonadotrope and pre-thyrotrope cells delays gonadotrope differentiation, with Hey1 as a candidate mediator; gonadotrope differentiation eventually completes but is mutually exclusive with Notch2 transgene expression, demonstrating that activated Notch2 is sufficient to delay pituitary progenitor differentiation.","method":"Transgenic mice expressing activated NOTCH2 ICD under alphaGSU promoter, histology, immunostaining for LH/FSH/Hey1","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function transgenic model with defined cellular phenotype and candidate downstream mediator (Hey1); single lab","pmids":["16840533"],"is_preprint":false},{"year":2007,"finding":"Notch2 ICD expression induces apoptosis in MDA-MB-231 breast adenocarcinoma cells and potently suppresses tumor xenograft growth in vivo, demonstrating a tumor-suppressive role distinct from the oncogenic Notch4 ICD in this context.","method":"Stable ICD expression, in vitro apoptosis assays, nude mouse xenograft tumor growth assay","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with both in vitro and in vivo phenotypic readouts; single lab","pmids":["17675579"],"is_preprint":false},{"year":2008,"finding":"RANKL induces expression of Jagged1 and Notch2 in bone marrow macrophages during osteoclastogenesis; Notch2 ICD and p65 (NF-κB) physically interact in the nucleus of RANKL-stimulated cells and are co-recruited to the NFATc1 promoter, driving NFATc1 expression and osteoclast differentiation.","method":"shRNA knockdown, gamma-secretase inhibitor, ectopic Notch2 ICD expression, luciferase reporter assay, Co-immunoprecipitation, chromatin immunoprecipitation (ChIP)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (Co-IP, ChIP, reporter assay, knockdown, overexpression) in a single study establishing molecular mechanism","pmids":["18710934"],"is_preprint":false},{"year":2010,"finding":"SCF (stem cell factor) signaling induces upregulation of Notch2 in primary human erythroblasts; functional inhibition of Notch or Jagged1 blocks SCF-mediated erythroid expansion, and dominant-negative Notch2 inhibits both basal and SCF-mediated erythroblast expansion while counteracting SCF-mediated delay of differentiation. SCF also induces Hes-1 and GATA-2 downstream of Notch2.","method":"Primary human erythroblast culture, dominant-negative Notch2 retroviral transduction, Notch/Jagged1 inhibitory antibodies, gene expression analysis","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional inhibition and dominant-negative approaches with defined phenotype; single lab, multiple methods","pmids":["20829885"],"is_preprint":false},{"year":2010,"finding":"Constitutive activation of Notch2 in Six2-positive nephron progenitor cells of the metanephric mesenchyme depletes the progenitor pool through ectopic Wnt4 expression and premature tubule formation, and suppresses Pax2 possibly through Hesr genes, revealing a positive feedback loop between Notch2 and Wnt4 in which Notch2 stabilizes nephron fate by shutting down progenitor maintenance.","method":"Conditional Notch2 gain-of-function mouse (Six2-Cre), histology, in situ hybridization, gene expression analysis","journal":"Journal of the American Society of Nephrology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional gain-of-function in vivo with defined cellular and molecular phenotype; single lab","pmids":["20299358"],"is_preprint":false},{"year":2011,"finding":"DC-specific deletion of Notch2 ablates the Esam(hi) CD11b+ DC subset in the spleen (which requires lymphotoxin beta receptor signaling and facilitates CD4+ T cell priming) and eliminates CD11b+CD103+ DCs in the intestinal lamina propria, demonstrating that Notch2 is a common differentiation signal for T cell-priming CD11b+ DC subsets.","method":"DC-specific Notch2 conditional knockout mice, flow cytometry, T cell priming assays, in vivo lymphotoxin beta receptor signaling analysis","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with multiple tissue readouts, functional T cell priming assays; replicated in multiple tissues","pmids":["22018469"],"is_preprint":false},{"year":2011,"finding":"Conditional deletion of Notch2 in the ocular lens causes microphthalmia, persistent lens stalks, disrupted fiber cell morphology, aberrant DNA synthesis in fiber cells, denucleation defects, and cataracts; loss of Notch2 elevates Cdkn1a (p21), CyclinD2, and p63 while downregulating E-Cadherin, demonstrating roles for Notch2 in lens morphogenesis, apoptosis suppression, cell cycle withdrawal, and secondary fiber cell differentiation.","method":"Conditional Notch2 knockout (lens-specific Cre), histology, immunostaining, gene expression analysis, BrdU labeling","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific conditional knockout with multiple phenotypic and molecular readouts in a single rigorous study","pmids":["22173065"],"is_preprint":false},{"year":2011,"finding":"Functional analysis of NOTCH2 missense, nonsense, and splicing mutations found in Alagille syndrome patients demonstrated decreased Notch signaling activity for these variants, establishing loss-of-function as the molecular mechanism underlying NOTCH2-associated Alagille syndrome.","method":"Cell-based Notch signaling reporter assays for six patient-derived NOTCH2 mutations","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — functional signaling assays on multiple alleles; single lab","pmids":["22209762"],"is_preprint":false},{"year":2014,"finding":"Proteolytic activation of NOTCH2 requires sequential cleavage by ADAM10 metalloprotease and presenilin-1 or -2 (gamma-secretase) upon canonical Delta/Jagged ligand binding; ADAM17/TACE is not required for ligand-induced NOTCH2 signaling, establishing that NOTCH1, -2, and -3 share a common ADAM10-dependent activation mechanism.","method":"Notch signaling assays with ADAM10/ADAM17/presenilin knockout or inhibitor conditions, NOTCH2 cleavage assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical and functional dissection of proteolytic activation with multiple enzyme knockouts/inhibitors and multiple Notch paralogs compared","pmids":["24842903"],"is_preprint":false},{"year":2014,"finding":"Notch2 ICD-specific activation of Akt signaling protects podocytes from apoptosis; a Notch2 agonistic antibody ameliorates proteinuria and glomerulosclerosis in a nephrosis mouse model, and this protective effect is abolished by the Akt inhibitor triciribine, placing Notch2 upstream of Akt in podocyte survival.","method":"Notch2 agonistic monoclonal antibody in vivo, Notch2 siRNA knockdown in vitro, Akt inhibitor rescue experiment, mouse nephrosis model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro and in vivo experiments with pharmacological and genetic tools establishing Notch2→Akt pathway in podocytes","pmids":["24526233"],"is_preprint":false},{"year":2014,"finding":"Notch2 deletion in a KrasG12D-driven NSCLC mouse model dramatically increases carcinogenesis and accelerates death; Notch2-deficient tumors show increased beta-catenin expression, undifferentiated phenotype, and aggressive growth, while Notch1 regulates MAPK via HES1-DUSP1. Notch2 and Notch1 have opposing roles: Notch2 mediates differentiation and tumor suppression, Notch1 promotes tumor initiation.","method":"Conditional Notch1 and Notch2 receptor deletion in KrasG12D endogenous NSCLC mouse model, tumor morphometry, IHC, gene expression","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout in established endogenous cancer model with mechanistic pathway analysis; in vivo with histological and molecular validation","pmids":["24509876"],"is_preprint":false},{"year":2015,"finding":"Swapping the intracellular domains of Notch1 and Notch2 in mice shows their ICDs are functionally equivalent; differences in developmental outcomes between Notch1 and Notch2 are explained by differences in signal strength (number of ICD molecules reaching the nucleus) and duration (half-life of NICD-RBPjk-MAML-DNA complexes), with tissue-specific gamma-secretase complexes contributing to differential NICD stability.","method":"Knock-in ICD swap mice, T-cell development assays, skin differentiation, inner ear, lung, retina phenotyping; epistasis analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 / Strong — rigorous genetic epistasis using ICD swap knock-in mice across multiple tissue contexts with mechanistic interpretation","pmids":["26062937"],"is_preprint":false},{"year":2015,"finding":"Human NOTCH2 is resistant to ligand-independent activation by ADAM17 (TACE), unlike human NOTCH1 and murine Notch2, which both require ADAM17 for ligand-independent signaling; this reveals subtle but functionally important differences in the negative regulatory region (NRR) between NOTCH paralogs and between human and murine NOTCH2.","method":"Biochemical cleavage assays, cell-based Notch signaling assays, comparison of human vs. murine Notch1/Notch2 NRR","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — rigorous biochemical and functional comparison of human vs. murine receptors with multiple assays in a single focused study","pmids":["25918160"],"is_preprint":false},{"year":2015,"finding":"Simultaneous loss of Notch2 and Notch3 in vascular smooth muscle cells causes patent ductus arteriosus (PDA), aortic dilation, and subcutaneous hemorrhage, associated with decreased expression of smooth muscle contractile markers; these receptors have overlapping roles in vascular smooth muscle differentiation.","method":"Smooth muscle-specific Notch2 conditional knockout combined with global Notch3 deletion, vascular morphology analysis, IHC for contractile markers","journal":"Genesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis via combined knockout with defined vascular phenotype and molecular markers; single lab","pmids":["26453897"],"is_preprint":false},{"year":2017,"finding":"Notch2 blockade (but not Notch1 blockade) sensitizes hematopoietic stem/progenitor cells (HSPCs) to mobilization stimuli and promotes their egress from marrow; Notch2 loss decreases CXCR4 expression on HSCs through direct regulation of CXCR4 transcription by the Notch transcriptional protein RBPJ.","method":"Notch receptor-blocking antibodies in vivo, conditional Notch2 knockout mice, flow cytometry, CXCR4 expression analysis, ChIP for RBPJ on CXCR4 promoter","journal":"Haematologica","confidence":"High","confidence_rationale":"Tier 1 / Strong — antibody blockade, genetic knockout, and ChIP demonstrating direct transcriptional regulation; multiple orthogonal methods","pmids":["28729299"],"is_preprint":false},{"year":2018,"finding":"Notch2, but not Notch1, conveys quiescence to ventricular-subventricular zone (V-SVZ) neural stem cells (NSCs) by repressing cell-cycle-related genes and neurogenesis; loss of Notch2 activates quiescent NSCs leading to accelerated exhaustion and an aging-like phenotype.","method":"Conditional Notch2 knockout mice (V-SVZ NSC-specific), BrdU/EdU labeling, gene expression analysis, comparison with Notch1 and Rbpj knockouts","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with clear quiescence phenotype, comparison across Notch paralogs and canonical signaling","pmids":["29386140"],"is_preprint":false},{"year":2018,"finding":"Notch2 is the primary determinant of hepatocyte-derived intrahepatic cholangiocarcinoma (ICC) formation; deletion of Notch2 (but not Notch1) in AKT/Yap-induced tumors switches phenotype from ICC to hepatocellular adenoma-like lesions, and Notch2 silencing in ICC cell lines downregulates the biliary markers Sox9 and EpCAM.","method":"Notch1/Notch2 conditional knockout mice, AKT/Yap hydrodynamic injection model, lineage tracing, siRNA knockdown in human ICC/HCC lines, Western blot","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockouts with lineage tracing and in vitro validation; two complementary genetic approaches","pmids":["29545603"],"is_preprint":false},{"year":2018,"finding":"Jagged1/Notch2 signaling in renal tubular epithelial cells drives kidney fibrosis by directly targeting the mitochondrial transcription factor Tfam; re-expression of Tfam prevents Notch-induced metabolic and profibrotic reprogramming; tubule-specific deletion of Jag1 or Notch2 (but not Notch1 or Notch3) protects from folic acid-induced nephropathy.","method":"Tubule-specific Jag1 and Notch2 conditional knockout mice, folic acid nephropathy model, ChIP for Notch target on Tfam promoter, genome-wide expression studies, Tfam re-expression rescue","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — conditional knockouts, ChIP establishing direct target, genome-wide expression, and rescue experiment; multiple orthogonal methods","pmids":["30226866"],"is_preprint":false},{"year":2018,"finding":"MINAR1 (KIAA1024/UPF0258) physically interacts with Notch2, increases its stability and signaling function, and negatively regulates angiogenesis; MINAR1 is a large intrinsically disordered protein with a single transmembrane domain expressed in breast epithelial and endothelial cells.","method":"Co-immunoprecipitation, pulldown, angiogenesis assays (cell culture, matrigel plug, zebrafish model), breast cancer xenograft model","journal":"Journal of molecular cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP establishing physical interaction plus functional in vitro and in vivo angiogenesis assays; single lab","pmids":["29329397"],"is_preprint":false},{"year":2019,"finding":"Id4 is a direct downstream target of Notch2 signaling in hippocampal dentate gyrus NSCs and maintains quiescence by blocking cell-cycle entry; Id4 expression is sufficient to promote NSC quiescence, Id4 knockdown rescues Notch2-induced inhibition of NSC proliferation, establishing a Notch2-Id4 axis that uncouples NSC activation from neuronal differentiation.","method":"Conditional Notch2 knockout, Id4 knockout and overexpression mice, lentiviral Id4 knockdown, BrdU labeling, gene expression analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with rescue experiment establishing Notch2→Id4 pathway; multiple orthogonal genetic tools","pmids":["31390563"],"is_preprint":false},{"year":2019,"finding":"NOTCH2 intracellular domain (N2ICD) interacts with TRAF6 via immunoprecipitation, attenuating the TRAF6-AKT signaling axis to inhibit epithelial-mesenchymal transition (EMT) and suppress metastasis in nasopharyngeal carcinoma.","method":"Immunoprecipitation, Western blot, cell migration/invasion assays, mouse tumor metastasis models, GSEA","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP establishing N2ICD-TRAF6 interaction plus functional validation in vitro and in vivo; single lab","pmids":["31699119"],"is_preprint":false},{"year":2020,"finding":"Fringe enzymes differentially modulate NOTCH2 vs. NOTCH1: Lunatic fringe (LFNG) enhances NOTCH2 activation by DLL1/DLL4 through O-fucosylation on EGF8 and EGF12, while Manic fringe (MFNG) inhibits NOTCH2 activation by JAG1/JAG2; a single O-fucose site mutant blocking MFNG inhibition of NOTCH2-JAG1 signaling was not identifiable (unlike NOTCH1). O-fucosylation on EGF9 is important for trafficking of both NOTCH1 and NOTCH2.","method":"Cell-based Notch signaling assays, ligand-binding assays, mass spectrometry (O-fucose site mapping), site-directed mutagenesis of O-fucose sites","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mass spectrometry mapping plus site-directed mutagenesis plus functional signaling assays; multiple orthogonal methods in one rigorous study","pmids":["32820046"],"is_preprint":false},{"year":2020,"finding":"DTX3 (Deltex E3 ubiquitin ligase 3) is a novel E3 ligase for NOTCH2; DTX3 promotes ubiquitination and proteasome-dependent degradation of NOTCH2, and DTX3 overexpression suppresses esophageal carcinoma cell proliferation and tumorigenicity.","method":"Yeast two-hybrid screening, Co-immunoprecipitation, ubiquitination assay, proteasome inhibitor experiments, overexpression/knockdown functional assays","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Y2H identification confirmed by Co-IP and ubiquitination assay with functional consequences; single lab","pmids":["31854042"],"is_preprint":false},{"year":2020,"finding":"CAFs-derived MFAP5 promotes bladder cancer by directly interacting with the NOTCH2 receptor to stimulate N2ICD release, activating the NOTCH2/HEY1 signaling pathway; DLL4/NOTCH2 pathway activation also mediates MFAP5 effects via PI3K-AKT signaling.","method":"Luciferase reporter assay, EMSA, Co-immunoprecipitation, shRNA knockdown, anti-NOTCH2 antibody (NRR2Mab), RNA-sequencing, in vivo xenograft","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction demonstrated by Co-IP and functional downstream activation by multiple assays; single lab","pmids":["32293074"],"is_preprint":false},{"year":2020,"finding":"The DLL1-NOTCH2 ligand-receptor pair is required for satellite cell self-renewal during muscle regeneration; differentiating satellite cells expressing Dll1 signal via NOTCH2 to neighboring cells to maintain the progenitor pool in a proportional feedback mechanism.","method":"Single-cell RNA-sequencing (identifying Notch2-enriched satellite cell subpopulation), antagonistic antibodies against DLL1 and NOTCH2, in vivo muscle regeneration assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — scRNA-seq identification followed by antibody-based functional validation in vivo; multiple methods","pmids":["32023464"],"is_preprint":false},{"year":2021,"finding":"Induced Notch2 ICD expression in mature follicular B (FoB) cells reprograms them into bona fide marginal zone B (MZB) cells (surface phenotype, localization, immunological function, transcriptome), demonstrating plasticity between mature B cell populations driven by a singular Notch2 signaling event.","method":"Inducible Notch2IC expression in FoB cells in immunocompetent mice, flow cytometry, transcriptome analysis, localization and functional assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — inducible gain-of-function in mature cells with comprehensive phenotypic, transcriptomic, and functional characterization","pmids":["33597542"],"is_preprint":false},{"year":2021,"finding":"CARM1 (coactivator-associated arginine methyltransferase 1) is recruited to the nucleus by Nup54, where it cooperates with TFEB to activate Notch2 transcription by inducing H3R17me2 (but not H3R26me2) at the Notch2 promoter; CARM1 also methylates the Notch2 ICD (N2ICD) at R1786, R1838, and R2047, which enhances N2ICD binding to MAML1 and promotes gastric cancer cell proliferation.","method":"ChIP-seq, RNA-seq, Co-IP (Nup54-CARM1 and N2ICD-MAML1 interactions), site-directed mutagenesis of N2ICD methylation sites, in vitro and in vivo proliferation assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — ChIP-seq, mutagenesis of modification sites, Co-IP of downstream complex, and functional rescue; multiple orthogonal methods","pmids":["34725461"],"is_preprint":false},{"year":2021,"finding":"The deubiquitinase OTUD1 interacts with Notch2-ICD (NICD) and cleaves ubiquitin from NICD at the K1770 site, thereby stabilizing NICD protein in activated CD4+ T cells and promoting Th1/Th17 differentiation and graft-versus-host disease.","method":"Co-immunoprecipitation, ubiquitination assay, site-specific K1770 deubiquitination, conditional knockout mice, GVHD model, FDA-approved drug screen","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-specific deubiquitination at K1770 established by biochemical assay, Co-IP, and in vivo functional validation","pmids":["36574342"],"is_preprint":false},{"year":2021,"finding":"FCER2 pulls down N2ICD (NOTCH2 intracellular domain) and N2ICD binds FCER2 in human spermatogonial stem cells (SSCs); the RNF144B-FCER2-NOTCH2/HES1 pathway regulates SSC proliferation and survival.","method":"Co-immunoprecipitation (RNF144B-FCER2; FCER2-N2ICD), RNA sequencing, siRNA/overexpression functional assays","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP establishing FCER2-N2ICD interaction with functional pathway validation; single lab","pmids":["35699595"],"is_preprint":false},{"year":2021,"finding":"Notch2 signaling directly promotes FOXP3 transcription and Treg cell differentiation in human CD4+ T cells in vitro; in an allergic rhinitis mouse model, Notch2 overexpression increased Treg cell differentiation and reduced allergic inflammation.","method":"In vitro human CD4+ T cell differentiation assay, luciferase reporter for FOXP3 transcription, lentiviral Notch2 overexpression in AR mouse model, flow cytometry for Treg cells","journal":"Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay establishing direct FOXP3 transcriptional activation, plus in vivo validation; single lab","pmids":["34480930"],"is_preprint":false},{"year":2022,"finding":"In skeletal muscle, multinucleated myofibers express Notch2, which is activated by endothelium-derived Dll4 released without direct cell-cell contact under atrophic conditions (disuse or diabetes); inhibition of the Dll4-Notch2 axis prevents muscle atrophy and promotes hypertrophy in mice.","method":"Conditional Notch2 knockout in myofibers, Dll4/Notch2 inhibitory antibodies, mouse models of disuse and diabetic atrophy and mechanical overload-induced hypertrophy, molecular analysis","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout and antibody blockade in multiple physiological and pathological in vivo models; replication across atrophy conditions","pmids":["35228746"],"is_preprint":false},{"year":2023,"finding":"KLHL6 is a novel E3 ubiquitin ligase that targets plasma membrane-associated NOTCH2 for proteasome-dependent degradation; DLBCL-associated NOTCH2 mutations cause protein escape from this KLHL6-mediated ubiquitin-dependent proteolysis, leading to NOTCH2 stabilization and activation of oncogenic RAS signaling in chemoresistant tumors.","method":"CRISPR-Cas9 cullin-RING ligase library screen, proteomic approaches identifying KLHL6-NOTCH2 interaction, ubiquitination assays, pharmacological rescue with gamma-secretase inhibitor and AKT inhibitor","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1 / Strong — CRISPR screen, proteomics, ubiquitination assays, and pharmacological rescue establishing the KLHL6-NOTCH2 degradation axis","pmids":["37235754"],"is_preprint":false},{"year":2023,"finding":"DLL1-induced NOTCH2 signaling efficiently induces the transition of Ly6Chi TREML4- monocytes into Ly6Clo TREML4+ nonclassical monocytes in vitro; this transition requires IRF2 but can occur without NUR77 or BCL6, establishing a transcriptional hierarchy downstream of Notch2 in monocyte development.","method":"In vitro DLL1-driven Notch2 activation, myeloid-specific BCL6/IRF2 knockout mice, flow cytometry for monocyte subset phenotype","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro Notch2 activation combined with genetic epistasis; single lab","pmids":["37607223"],"is_preprint":false},{"year":2023,"finding":"A pan-cancer tRNA-derived fragment CAT1 binds RBPMS and displaces NOTCH2 mRNA from RBPMS, thereby inhibiting CCR4-NOT deadenylation complex-mediated NOTCH2 mRNA decay and stabilizing NOTCH2 mRNA to promote lung cancer proliferation and metastasis.","method":"RNA pulldown, RIP assay, NOTCH2 mRNA stability assay, CAT1 overexpression/knockdown in vitro and in vivo","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA pulldown and RIP establishing CAT1-RBPMS-NOTCH2 mRNA interaction with functional validation; single lab","pmids":["37943661"],"is_preprint":false},{"year":2023,"finding":"NOTCH2 gain-of-function enhances osteoclastogenesis by upregulating cell metabolism, aerobic respiration, and mitochondrial function in osteoclast progenitors; these pathways are not enhanced in the context of Hes1 inactivation, placing Hes1 as an obligate mediator of NOTCH2-driven osteoclast metabolic enhancement.","method":"Bulk RNA-seq, single-cell RNA-seq, pseudotime trajectory analysis of Notch2 gain-of-function (Notch2tm1.1Ecan) and Hes1-conditional knockout bone marrow macrophages","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA-seq and scRNA-seq with genetic epistasis establishing Hes1-dependency; single lab","pmids":["38159855"],"is_preprint":false},{"year":2023,"finding":"NOTCH2 gain-of-function enhances TNFα-induced Il6 and Il1b expression in chondrocytes; TNFα displaces RBPJκ from DNA binding sites (demonstrated by EMSA), explaining both increased Il6 expression and concomitant decrease in canonical Notch target genes Hes1/Hey1/Hey2/Heyl. NOTCH2 also enhances TNFα-activated NF-κB signaling.","method":"Notch2 gain-of-function mouse chondrocytes (Notch2tm1.1Ecan), NOTCH2-ICD overexpression, EMSA for RBPJκ DNA binding, RNA-seq, NF-κB signaling assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — EMSA establishing displacement mechanism, RNA-seq, multiple genetic and overexpression models, and pharmacological analysis","pmids":["37865314"],"is_preprint":false},{"year":2024,"finding":"NOTCH2 mediates immune escape in hepatocellular carcinoma by NETs-activated NF-κB pathway upregulating CD73, which promotes regulatory T cell infiltration; DNase I inhibition of NETs reduces this NOTCH2-mediated CD73 upregulation.","method":"In vitro NETs stimulation, NOTCH2 pathway analysis, CD73 expression assays, mouse HCC model by hydrodynamic plasmid transfection, anti-PD-1 combination experiments","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo mechanistic experiments; single lab with multiple assays","pmids":["38969159"],"is_preprint":false},{"year":2024,"finding":"Notch2 signaling controls the fate decision between germinal center (GC) B cells and marginal zone B (MZB) cells upon immunization: antigen-activated FoB cells that turn off Notch2 signaling enter GCs, while high Notch2 signaling drives MZB cell generation or plasmablast differentiation; mathematical modeling supports a binary Notch2-dependent fate decision.","method":"Conditional Notch2 ablation and constitutive activation in B cells during T-cell-dependent immunization, flow cytometry for B cell subsets, mathematical modeling","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — complementary gain- and loss-of-function genetic models in vivo with quantitative modeling; replicates and extends prior work on Notch2 in B cell fate","pmids":["38438375"],"is_preprint":false},{"year":2024,"finding":"ADAM10 regulates NOTCH2 protein expression in colorectal cancer; the NOTCH2 ICD directly activates TCF7L2 transcription and Wnt target genes (MYC, JUN, CCND1/2) without directly interacting with TCF7L2 protein, establishing a NOTCH2-mediated transcriptional regulation of the Wnt pathway axis.","method":"High-throughput organoid drug screening, ADAM10 knockdown/inhibition, NOTCH2 and TCF7L2 Co-IP (negative for direct interaction), ChIP or transcriptional reporter assays for TCF7L2 regulation","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — organoid screening combined with mechanistic dissection; negative Co-IP (no direct NOTCH2-TCF7L2 interaction) is a negative result; transcriptional activation is supported; single lab","pmids":["39601111"],"is_preprint":false}],"current_model":"NOTCH2 is a type I transmembrane receptor activated by sequential ADAM10- and gamma-secretase (presenilin)-mediated proteolysis upon binding Delta-like or Jagged ligands, releasing the ICD (N2ICD) that forms a transcriptional activation complex with RBPJκ and MAML1 to drive HES/HEY target gene expression; its signaling strength and duration (governed by tissue-specific gamma-secretase activity and post-translational modifications including O-fucosylation by Fringe enzymes, arginine methylation by CARM1, and ubiquitination/deubiquitination by KLHL6/DTX3/OTUD1) determines cell fate outcomes across diverse contexts including DC differentiation, B cell MZB vs. GC fate decisions, neural stem cell quiescence, osteoclastogenesis, kidney fibrosis, nephron development, muscle mass regulation, and tumor suppression or promotion depending on cell type."},"narrative":{"mechanistic_narrative":"NOTCH2 is a type I transmembrane receptor that converts ligand engagement into transcriptional output to control cell-fate decisions across developmental, immune, skeletal, and oncogenic contexts [PMID:1295745, PMID:26062937]. Productive signaling requires sequential proteolysis: upon Delta-like/Jagged ligand binding, ADAM10 (not ADAM17) and presenilin-dependent gamma-secretase cleave the receptor to release the intracellular domain (N2ICD), which enters the nucleus and assembles with RBPJκ and MAML1 to drive HES/HEY target gene transcription [PMID:24842903, PMID:34725461]. Ligand selectivity and signal strength are tuned at the cell surface by Fringe-mediated O-fucosylation, where Lunatic fringe enhances DLL1/DLL4-driven activation and Manic fringe restrains Jagged-driven activation [PMID:32820046], and human NOTCH2 is distinguished from NOTCH1 and murine Notch2 by resistance to ligand-independent ADAM17 cleavage [PMID:25918160]; ICD-swap experiments establish that the NOTCH1 and NOTCH2 ICDs are intrinsically equivalent, so paralog-specific outcomes reflect differences in signal strength and N2ICD duration set by tissue-specific gamma-secretase [PMID:26062937]. N2ICD abundance is further governed post-translationally by E3 ligases KLHL6 and DTX3, the deubiquitinase OTUD1 (acting at K1770), and arginine methylation by CARM1 that strengthens N2ICD–MAML1 binding [PMID:37235754, PMID:31854042, PMID:36574342, PMID:34725461]. Through this machinery NOTCH2 directs nephron progenitor and lens differentiation [PMID:20299358, PMID:22173065], drives CD11b+ dendritic cell and marginal-zone vs. germinal-center B cell fate decisions [PMID:22018469, PMID:33597542, PMID:38438375], imposes quiescence on neural stem cells via an Id4 axis [PMID:29386140, PMID:31390563], promotes osteoclastogenesis through NF-κB/NFATc1 [PMID:18710934, PMID:38159855], and regulates muscle mass via an endothelial Dll4–Notch2 axis [PMID:35228746]. In cancer it is context-dependent, acting as a differentiation-promoting tumor suppressor in lung and breast models while being stabilized by oncogenic mutation in lymphoma [PMID:24509876, PMID:17675579, PMID:37235754]. Loss-of-function NOTCH2 mutations that reduce signaling cause Alagille syndrome [PMID:22209762].","teleology":[{"year":1992,"claim":"Establishing NOTCH2 as a distinct mammalian Notch paralog defined the receptor as a candidate fate-determining molecule with its own expression domains rather than a redundant copy of Notch1.","evidence":"cDNA cloning with Northern blot and in situ hybridization expression profiling","pmids":["1295745"],"confidence":"Medium","gaps":["No functional or signaling mechanism defined","Ligand and downstream targets unknown at this stage"]},{"year":1999,"claim":"Genetic disruption of the cytoplasmic ankyrin repeats showed they are indispensable and that Notch2 has non-redundant functions distinct from Notch1, framing the ICD as the functional effector.","evidence":"Knock-in gene targeting replacing ankyrin repeats in mice, with TUNEL and in situ readouts","pmids":["10393120"],"confidence":"High","gaps":["Did not resolve which downstream complex the ankyrin repeats engage","Embryonic lethality limited tissue-specific analysis"]},{"year":2002,"claim":"Comparing ICD transcriptional activities revealed paralog-specific, RBPJκ-dependent effects on HES promoters, raising the question of how paralog identity translates into distinct outputs.","evidence":"Luciferase reporter assays on HES1/HES5 promoters with truncated ICD constructs","pmids":["11866432"],"confidence":"Medium","gaps":["In vitro overexpression may not reflect physiological stoichiometry","Cross-suppression mechanism not defined"]},{"year":2008,"claim":"Defining the Notch2 ICD–p65 interaction at the NFATc1 promoter established a concrete molecular mechanism coupling Notch2 to NF-κB during osteoclastogenesis.","evidence":"Co-IP, ChIP, reporter assays, knockdown and ICD overexpression in bone marrow macrophages","pmids":["18710934"],"confidence":"High","gaps":["Whether NF-κB cooperation generalizes beyond osteoclasts unclear at the time","Direct contact surface between N2ICD and p65 not mapped"]},{"year":2011,"claim":"Tissue-specific knockouts established non-redundant Notch2 roles in dendritic cell differentiation and lens morphogenesis, moving the receptor from candidate to validated fate determinant in defined cell types.","evidence":"DC-specific and lens-specific conditional knockout mice with flow cytometry, T cell priming assays, histology and gene expression","pmids":["22018469","22173065"],"confidence":"High","gaps":["Direct transcriptional targets in these tissues not fully defined","Ligand source driving activation in vivo not always identified"]},{"year":2011,"claim":"Demonstrating that Alagille-associated NOTCH2 variants reduce signaling established loss-of-function as the disease mechanism, linking quantitative signaling output to human pathology.","evidence":"Cell-based Notch reporter assays on six patient-derived NOTCH2 mutations","pmids":["22209762"],"confidence":"Medium","gaps":["Tissue-level consequences of partial signaling loss not modeled","Single assay system for diverse mutation types"]},{"year":2014,"claim":"Dissecting the proteolytic cascade established that NOTCH2 activation depends on ADAM10 and presenilin gamma-secretase but not ADAM17, defining the canonical activation route shared with other Notch paralogs.","evidence":"Notch signaling and cleavage assays under ADAM10/ADAM17/presenilin knockout or inhibitor conditions","pmids":["24842903"],"confidence":"High","gaps":["Did not address ligand-independent activation differences between species","Spatial site of cleavage not resolved"]},{"year":2014,"claim":"Knockouts in cancer and kidney models revealed that Notch2 can act as a tumor suppressor promoting differentiation and can signal to Akt for podocyte survival, expanding its functions beyond canonical HES transcription.","evidence":"Conditional Notch2 deletion in KrasG12D NSCLC model; Notch2 agonist antibody plus Akt inhibitor rescue in nephrosis model","pmids":["24509876","24526233"],"confidence":"High","gaps":["Mechanism linking N2ICD to Akt not biochemically defined","Cell-type basis of tumor suppressor vs. oncogenic switch unresolved"]},{"year":2015,"claim":"ICD-swap and NRR comparison experiments resolved why paralogs differ: the ICDs are intrinsically equivalent and outcomes depend on signal strength, ICD duration, and species/paralog-specific regulatory regions.","evidence":"Knock-in ICD-swap mice across multiple tissues; biochemical NRR comparison of human vs. murine Notch1/Notch2","pmids":["26062937","25918160"],"confidence":"High","gaps":["Molecular determinants setting tissue-specific gamma-secretase activity not identified","Quantitative ICD thresholds for fate decisions not measured"]},{"year":2018,"claim":"Multiple in vivo studies established Notch2 as a controller of stem cell quiescence and lineage selection, with a defined Notch2→Id4 axis and direct profibrotic targeting of Tfam, showing how the receptor reprograms differentiation and metabolism.","evidence":"Conditional knockouts in V-SVZ NSCs and renal tubular epithelium; ChIP on Tfam promoter; Tfam rescue; later Id4 epistasis with rescue","pmids":["29386140","30226866","31390563"],"confidence":"High","gaps":["How Notch2 selects quiescence vs. proliferation programs not fully defined","Direct vs. indirect target relationships vary by tissue"]},{"year":2020,"claim":"Identifying Fringe-mediated O-fucosylation and E3 ligase DTX3 control established two layers—glycosylation and ubiquitin-dependent degradation—that tune NOTCH2 ligand selectivity and abundance.","evidence":"Mass spectrometry O-fucose site mapping with mutagenesis and signaling assays; Y2H, Co-IP and ubiquitination assays for DTX3","pmids":["32820046","31854042"],"confidence":"High","gaps":["In vivo relevance of individual O-fucose sites for NOTCH2 incompletely defined","DTX3 regulation primarily shown in cancer cell systems"]},{"year":2021,"claim":"Discovery of CARM1 methylation of N2ICD and OTUD1 deubiquitination at K1770 established post-translational control of N2ICD stability and of its binding to MAML1, directly linking modification state to transcriptional output.","evidence":"ChIP-seq, site-directed mutagenesis of methylation sites, Co-IP of N2ICD-MAML1; site-specific K1770 deubiquitination assays with conditional knockouts and GVHD model","pmids":["34725461","36574342"],"confidence":"High","gaps":["Interplay between methylation, ubiquitination, and degradation not integrated","Generality across tissues beyond gastric cancer and T cells untested"]},{"year":2021,"claim":"Inducible B-cell experiments established that a single Notch2 signaling event reprograms follicular B cells to marginal-zone identity, demonstrating Notch2 as a binary fate switch in mature cells.","evidence":"Inducible Notch2IC expression in mature FoB cells with transcriptome and functional characterization","pmids":["33597542"],"confidence":"High","gaps":["Physiological trigger of the switch in vivo not defined here","Stability/reversibility of reprogrammed state untested"]},{"year":2022,"claim":"Identifying an endothelial Dll4–Notch2 axis acting on multinucleated myofibers without cell-cell contact extended Notch2 signaling to muscle mass regulation and a non-classical ligand presentation mode.","evidence":"Myofiber conditional knockout and Dll4/Notch2 blocking antibodies across disuse, diabetic atrophy and overload-hypertrophy models","pmids":["35228746"],"confidence":"High","gaps":["Mechanism of contact-independent ligand delivery not resolved","Downstream transcriptional program in myofibers not detailed"]},{"year":2023,"claim":"Defining KLHL6 as an E3 ligase whose evasion by DLBCL mutations stabilizes NOTCH2 established a mutation-driven oncogenic mechanism and connected NOTCH2 stability to RAS signaling.","evidence":"CRISPR cullin-RING ligase screen, proteomics, ubiquitination assays, pharmacological rescue with gamma-secretase and AKT inhibitors","pmids":["37235754"],"confidence":"High","gaps":["Mechanism linking stabilized NOTCH2 to RAS activation not fully mapped","Whether KLHL6 control operates in non-lymphoid tissues unknown"]},{"year":2023,"claim":"Mechanistic studies revealed that NOTCH2 output can occur through non-canonical routes, including TNFα-driven RBPJκ displacement in chondrocytes and Hes1-dependent metabolic reprogramming in osteoclasts, refining how context redirects signaling.","evidence":"Notch2 gain-of-function mouse cells with EMSA for RBPJκ binding, RNA-seq, scRNA-seq and Hes1 epistasis","pmids":["37865314","38159855"],"confidence":"Medium","gaps":["Generality of RBPJκ displacement mechanism beyond chondrocytes untested","Single-lab models for the gain-of-function allele"]},{"year":2024,"claim":"Complementary B-cell and cancer studies refined Notch2 as a quantitative binary fate determinant (GC vs. MZB) and showed Wnt-pathway crosstalk via N2ICD activation of TCF7L2 transcription without direct protein interaction.","evidence":"Conditional ablation and constitutive activation in B cells with mathematical modeling; organoid screening, ADAM10 modulation, and negative N2ICD-TCF7L2 Co-IP with transcriptional assays","pmids":["38438375","39601111"],"confidence":"High","gaps":["Indirect mechanism of TCF7L2 transcriptional activation not fully resolved","Thresholds setting the GC vs. MZB decision in physiological immunization incompletely quantified"]},{"year":null,"claim":"How the layered control of N2ICD dose and duration—glycosylation, methylation, ubiquitination/deubiquitination, and tissue-specific gamma-secretase—integrates to produce opposite (tumor-suppressive vs. oncogenic) outcomes in different cell types remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified quantitative model linking modification state to fate output","Determinants of cell-type-specific tumor suppressor vs. oncogene behavior undefined","Crosstalk hierarchy among the post-translational regulators not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,5,29,38,41]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[11,14,24,27]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,17,38]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[11,15,34]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,29,30]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[11,14,24]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[7,9,16,27]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8,28,30,32,35,40]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[10,13,34]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[25,29,30,34]}],"complexes":["N2ICD-RBPJk-MAML1 transcriptional activation complex"],"partners":["RBPJ","MAML1","ADAM10","CARM1","KLHL6","DTX3","OTUD1","TRAF6"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q04721","full_name":"Neurogenic locus notch homolog protein 2","aliases":[],"length_aa":2471,"mass_kda":265.4,"function":"Functions as a receptor for membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus (PubMed:21378985, PubMed:21378989). Affects the implementation of differentiation, proliferation and apoptotic programs (By similarity). Involved in bone remodeling and homeostasis. In collaboration with RELA/p65 enhances NFATc1 promoter activity and positively regulates RANKL-induced osteoclast differentiation (PubMed:29149593). Positively regulates self-renewal of liver cancer cells (PubMed:25985737)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q04721/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NOTCH2","classification":"Not Classified","n_dependent_lines":13,"n_total_lines":1208,"dependency_fraction":0.01076158940397351},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NOTCH2","total_profiled":1310},"omim":[{"mim_id":"621120","title":"DELTA-LIKE NONCANONICAL NOTCH LIGAND 2; DLK2","url":"https://www.omim.org/entry/621120"},{"mim_id":"620468","title":"VERTEBRAE DEVELOPMENT-ASSOCIATED GENE; VRTN","url":"https://www.omim.org/entry/620468"},{"mim_id":"620238","title":"DEAFNESS, AUTOSOMAL RECESSIVE 120; DFNB120","url":"https://www.omim.org/entry/620238"},{"mim_id":"620215","title":"MEMBRANE INTEGRAL NOTCH2-ASSOCIATED RECEPTOR 2; MINAR2","url":"https://www.omim.org/entry/620215"},{"mim_id":"619473","title":"OCULOPHARYNGODISTAL MYOPATHY 3; OPDM3","url":"https://www.omim.org/entry/619473"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Plasma membrane","reliability":"Supported"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NOTCH2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q04721","domains":[{"cath_id":"2.10.25","chopping":"116-151","consensus_level":"medium","plddt":65.0536,"start":116,"end":151},{"cath_id":"2.10.25.10","chopping":"208-299","consensus_level":"medium","plddt":69.7276,"start":208,"end":299},{"cath_id":"-","chopping":"389-413_432-461_474-483","consensus_level":"medium","plddt":68.7771,"start":389,"end":483},{"cath_id":"2.10.25.10","chopping":"506-536","consensus_level":"high","plddt":65.5323,"start":506,"end":536},{"cath_id":"2.10.25.10","chopping":"557-604","consensus_level":"high","plddt":63.8081,"start":557,"end":604},{"cath_id":"-","chopping":"654-680","consensus_level":"medium","plddt":69.9681,"start":654,"end":680},{"cath_id":"2.10.25","chopping":"913-942","consensus_level":"medium","plddt":66.824,"start":913,"end":942},{"cath_id":"2.10.25.10","chopping":"1034-1201","consensus_level":"medium","plddt":69.2955,"start":1034,"end":1201},{"cath_id":"2.10.25.10","chopping":"1307-1343","consensus_level":"medium","plddt":62.8511,"start":1307,"end":1343},{"cath_id":"3.30.70.3310","chopping":"1462-1501_1539-1592_1620-1670","consensus_level":"medium","plddt":77.7975,"start":1462,"end":1670}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q04721","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q04721-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q04721-F1-predicted_aligned_error_v6.png","plddt_mean":59.41},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NOTCH2","jax_strain_url":"https://www.jax.org/strain/search?query=NOTCH2"},"sequence":{"accession":"Q04721","fasta_url":"https://rest.uniprot.org/uniprotkb/Q04721.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q04721/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q04721"}},"corpus_meta":[{"pmid":"22018469","id":"PMC_22018469","title":"Notch2 receptor signaling controls functional differentiation of dendritic cells in the spleen and intestine.","date":"2011","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/22018469","citation_count":434,"is_preprint":false},{"pmid":"1295745","id":"PMC_1295745","title":"Notch2: a second mammalian Notch gene.","date":"1992","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1295745","citation_count":321,"is_preprint":false},{"pmid":"10393120","id":"PMC_10393120","title":"Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10393120","citation_count":238,"is_preprint":false},{"pmid":"25558064","id":"PMC_25558064","title":"Notch2 is required for inflammatory cytokine-driven goblet cell metaplasia in the lung.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25558064","citation_count":201,"is_preprint":false},{"pmid":"22209762","id":"PMC_22209762","title":"NOTCH2 mutations in Alagille syndrome.","date":"2011","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22209762","citation_count":162,"is_preprint":false},{"pmid":"18710934","id":"PMC_18710934","title":"The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18710934","citation_count":151,"is_preprint":false},{"pmid":"31343788","id":"PMC_31343788","title":"Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31343788","citation_count":113,"is_preprint":false},{"pmid":"17675579","id":"PMC_17675579","title":"Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth.","date":"2007","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17675579","citation_count":100,"is_preprint":false},{"pmid":"29545603","id":"PMC_29545603","title":"Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29545603","citation_count":98,"is_preprint":false},{"pmid":"29139178","id":"PMC_29139178","title":"Notch1 and Notch2 Coordinately Regulate Stem Cell Function in the Quiescent and Activated States of Muscle Satellite Cells.","date":"2017","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/29139178","citation_count":93,"is_preprint":false},{"pmid":"29386140","id":"PMC_29386140","title":"Notch2 Signaling Maintains NSC Quiescence in the Murine Ventricular-Subventricular Zone.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29386140","citation_count":92,"is_preprint":false},{"pmid":"17080428","id":"PMC_17080428","title":"Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner.","date":"2007","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/17080428","citation_count":92,"is_preprint":false},{"pmid":"11866432","id":"PMC_11866432","title":"Functional diversity among Notch1, Notch2, and Notch3 receptors.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11866432","citation_count":90,"is_preprint":false},{"pmid":"31390563","id":"PMC_31390563","title":"Id4 Downstream of Notch2 Maintains Neural Stem Cell Quiescence in the Adult Hippocampus.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31390563","citation_count":81,"is_preprint":false},{"pmid":"26062937","id":"PMC_26062937","title":"The intracellular domains of Notch1 and Notch2 are functionally equivalent during development and carcinogenesis.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26062937","citation_count":76,"is_preprint":false},{"pmid":"30279176","id":"PMC_30279176","title":"Notch2-dependent DC2s mediate splenic germinal center responses.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30279176","citation_count":74,"is_preprint":false},{"pmid":"24842903","id":"PMC_24842903","title":"Regulated proteolysis of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24842903","citation_count":69,"is_preprint":false},{"pmid":"24509876","id":"PMC_24509876","title":"Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24509876","citation_count":69,"is_preprint":false},{"pmid":"30470250","id":"PMC_30470250","title":"miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.","date":"2018","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30470250","citation_count":68,"is_preprint":false},{"pmid":"31239543","id":"PMC_31239543","title":"Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry.","date":"2019","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31239543","citation_count":66,"is_preprint":false},{"pmid":"30226866","id":"PMC_30226866","title":"Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming.","date":"2018","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/30226866","citation_count":65,"is_preprint":false},{"pmid":"20299358","id":"PMC_20299358","title":"Notch2 activation in the embryonic kidney depletes nephron progenitors.","date":"2010","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/20299358","citation_count":60,"is_preprint":false},{"pmid":"32820046","id":"PMC_32820046","title":"Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32820046","citation_count":59,"is_preprint":false},{"pmid":"28733035","id":"PMC_28733035","title":"MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28733035","citation_count":57,"is_preprint":false},{"pmid":"26933171","id":"PMC_26933171","title":"Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis.","date":"2016","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/26933171","citation_count":56,"is_preprint":false},{"pmid":"7609614","id":"PMC_7609614","title":"Differential expression of Notch1 and Notch2 in developing and adult mouse brain.","date":"1995","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/7609614","citation_count":55,"is_preprint":false},{"pmid":"23299462","id":"PMC_23299462","title":"MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression.","date":"2013","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23299462","citation_count":54,"is_preprint":false},{"pmid":"16840533","id":"PMC_16840533","title":"Persistent expression of Notch2 delays gonadotrope differentiation.","date":"2006","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/16840533","citation_count":53,"is_preprint":false},{"pmid":"32077168","id":"PMC_32077168","title":"Aberrant expression of miR-29b-3p influences heart development and cardiomyocyte proliferation by targeting NOTCH2.","date":"2020","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/32077168","citation_count":53,"is_preprint":false},{"pmid":"21466361","id":"PMC_21466361","title":"Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers.","date":"2011","source":"Archives of pathology & laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21466361","citation_count":52,"is_preprint":false},{"pmid":"32023464","id":"PMC_32023464","title":"Heterogeneity of Satellite Cells Implicates DELTA1/NOTCH2 Signaling in Self-Renewal.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32023464","citation_count":52,"is_preprint":false},{"pmid":"31218097","id":"PMC_31218097","title":"The role of oncogenic Notch2 signaling in cancer: a novel therapeutic target.","date":"2019","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31218097","citation_count":51,"is_preprint":false},{"pmid":"31619270","id":"PMC_31619270","title":"JAG2/Notch2 inhibits intervertebral disc degeneration by modulating cell proliferation, apoptosis, and extracellular matrix.","date":"2019","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31619270","citation_count":47,"is_preprint":false},{"pmid":"24574459","id":"PMC_24574459","title":"NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24574459","citation_count":47,"is_preprint":false},{"pmid":"12531696","id":"PMC_12531696","title":"Notch2 protein distribution in human teeth under normal and pathological conditions.","date":"2003","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12531696","citation_count":46,"is_preprint":false},{"pmid":"32293074","id":"PMC_32293074","title":"CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32293074","citation_count":46,"is_preprint":false},{"pmid":"24223455","id":"PMC_24223455","title":"Increased LEF1 expression and decreased Notch2 expression are strong predictors of poor outcomes in colorectal cancer patients.","date":"2013","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/24223455","citation_count":45,"is_preprint":false},{"pmid":"27932500","id":"PMC_27932500","title":"NOTCH1 and NOTCH2 regulate epithelial cell proliferation in mouse and human gastric corpus.","date":"2016","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27932500","citation_count":44,"is_preprint":false},{"pmid":"26041881","id":"PMC_26041881","title":"The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26041881","citation_count":44,"is_preprint":false},{"pmid":"22173065","id":"PMC_22173065","title":"Conditional ablation of the Notch2 receptor in the ocular lens.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22173065","citation_count":42,"is_preprint":false},{"pmid":"35228746","id":"PMC_35228746","title":"The endothelial Dll4-muscular Notch2 axis regulates skeletal muscle mass.","date":"2022","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/35228746","citation_count":40,"is_preprint":false},{"pmid":"31699119","id":"PMC_31699119","title":"NOTCH2 negatively regulates metastasis and epithelial-Mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/31699119","citation_count":40,"is_preprint":false},{"pmid":"38969159","id":"PMC_38969159","title":"Neutrophil extracellular traps promote immune escape in hepatocellular carcinoma by up-regulating CD73 through Notch2.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38969159","citation_count":37,"is_preprint":false},{"pmid":"24508387","id":"PMC_24508387","title":"Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture.","date":"2014","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/24508387","citation_count":37,"is_preprint":false},{"pmid":"33597542","id":"PMC_33597542","title":"Notch2-mediated plasticity between marginal zone and follicular B cells.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33597542","citation_count":37,"is_preprint":false},{"pmid":"24526233","id":"PMC_24526233","title":"Notch2 activation ameliorates nephrosis.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24526233","citation_count":35,"is_preprint":false},{"pmid":"27241678","id":"PMC_27241678","title":"Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations.","date":"2016","source":"Current osteoporosis reports","url":"https://pubmed.ncbi.nlm.nih.gov/27241678","citation_count":35,"is_preprint":false},{"pmid":"19653042","id":"PMC_19653042","title":"Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status.","date":"2009","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19653042","citation_count":35,"is_preprint":false},{"pmid":"29706630","id":"PMC_29706630","title":"lncAKHE enhances cell growth and migration in hepatocellular carcinoma via activation of NOTCH2 signaling.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29706630","citation_count":34,"is_preprint":false},{"pmid":"25659500","id":"PMC_25659500","title":"Expression pattern and function of Notch2 in different subtypes of first trimester cytotrophoblast.","date":"2015","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/25659500","citation_count":27,"is_preprint":false},{"pmid":"29915190","id":"PMC_29915190","title":"Mesenchymal stem cell-mediated Notch2 activation overcomes radiation-induced injury of the hematopoietic system.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29915190","citation_count":27,"is_preprint":false},{"pmid":"31854042","id":"PMC_31854042","title":"Ubiquitination of NOTCH2 by DTX3 suppresses the proliferation and migration of human esophageal carcinoma.","date":"2020","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/31854042","citation_count":27,"is_preprint":false},{"pmid":"26453897","id":"PMC_26453897","title":"Loss of Notch2 and Notch3 in vascular smooth muscle causes patent ductus arteriosus.","date":"2015","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/26453897","citation_count":27,"is_preprint":false},{"pmid":"31186700","id":"PMC_31186700","title":"NOTCH2/NOTCH3/DLL3/MAML1/ADAM17 signaling network is associated with ovarian cancer.","date":"2019","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31186700","citation_count":26,"is_preprint":false},{"pmid":"33309869","id":"PMC_33309869","title":"Notch1 and Notch2 collaboratively maintain radial glial cells in mouse neurogenesis.","date":"2020","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/33309869","citation_count":25,"is_preprint":false},{"pmid":"39505846","id":"PMC_39505846","title":"Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockade.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39505846","citation_count":24,"is_preprint":false},{"pmid":"38462037","id":"PMC_38462037","title":"LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38462037","citation_count":24,"is_preprint":false},{"pmid":"23277114","id":"PMC_23277114","title":"The expression of NOTCH2, HES1 and SOX9 during mouse retinal development.","date":"2012","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/23277114","citation_count":24,"is_preprint":false},{"pmid":"34296965","id":"PMC_34296965","title":"Notch2 suppression mimicking changes in human pulmonary hypertension modulates Notch1 and promotes endothelial cell proliferation.","date":"2021","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/34296965","citation_count":24,"is_preprint":false},{"pmid":"34480930","id":"PMC_34480930","title":"Notch2 suppresses the development of allergic rhinitis by promoting FOXP3 expression and Treg cell differentiation.","date":"2021","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34480930","citation_count":24,"is_preprint":false},{"pmid":"33961511","id":"PMC_33961511","title":"MiR-485-3p promotes proliferation of osteoarthritis chondrocytes and inhibits apoptosis via Notch2 and the NF-κB pathway.","date":"2021","source":"Immunopharmacology and immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/33961511","citation_count":24,"is_preprint":false},{"pmid":"25381598","id":"PMC_25381598","title":"MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.","date":"2014","source":"World journal of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25381598","citation_count":24,"is_preprint":false},{"pmid":"28729299","id":"PMC_28729299","title":"Notch2 blockade enhances hematopoietic stem cell mobilization and homing.","date":"2017","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/28729299","citation_count":23,"is_preprint":false},{"pmid":"34725461","id":"PMC_34725461","title":"Nup54-induced CARM1 nuclear importation promotes gastric cancer cell proliferation and tumorigenesis through transcriptional activation and methylation of Notch2.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34725461","citation_count":23,"is_preprint":false},{"pmid":"37235754","id":"PMC_37235754","title":"DLBCL-associated NOTCH2 mutations escape ubiquitin-dependent degradation and promote chemoresistance.","date":"2023","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/37235754","citation_count":22,"is_preprint":false},{"pmid":"32770090","id":"PMC_32770090","title":"NOTCH2 participates in Jagged1-induced osteogenic differentiation in human periodontal ligament cells.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32770090","citation_count":22,"is_preprint":false},{"pmid":"25918160","id":"PMC_25918160","title":"Human NOTCH2 Is Resistant to Ligand-independent Activation by Metalloprotease Adam17.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25918160","citation_count":22,"is_preprint":false},{"pmid":"23349727","id":"PMC_23349727","title":"The different role of Notch1 and Notch2 in astrocytic gliomas.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23349727","citation_count":22,"is_preprint":false},{"pmid":"29875313","id":"PMC_29875313","title":"Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29875313","citation_count":21,"is_preprint":false},{"pmid":"20829885","id":"PMC_20829885","title":"The Notch2-Jagged1 interaction mediates stem cell factor signaling in erythropoiesis.","date":"2010","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/20829885","citation_count":21,"is_preprint":false},{"pmid":"30988799","id":"PMC_30988799","title":"miR-758-3p suppresses human bladder cancer cell proliferation, migration and invasion by targeting NOTCH2.","date":"2019","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30988799","citation_count":21,"is_preprint":false},{"pmid":"30304577","id":"PMC_30304577","title":"Functional evidence implicating NOTCH2 missense mutations in primary ovarian insufficiency etiology.","date":"2018","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/30304577","citation_count":20,"is_preprint":false},{"pmid":"37943661","id":"PMC_37943661","title":"Pan-cancer tRNA-derived fragment CAT1 coordinates RBPMS to stabilize NOTCH2 mRNA to promote tumorigenesis.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37943661","citation_count":20,"is_preprint":false},{"pmid":"10704869","id":"PMC_10704869","title":"Correlation of asymmetric Notch2 expression and mouse incisor rotation.","date":"2000","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10704869","citation_count":19,"is_preprint":false},{"pmid":"28278511","id":"PMC_28278511","title":"Mechanism of MicroRNA-146a/Notch2 Signaling Regulating IL-6 in Graves Ophthalmopathy.","date":"2017","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28278511","citation_count":19,"is_preprint":false},{"pmid":"31643078","id":"PMC_31643078","title":"MicroRNA-16 is involved in the pathogenesis of pre-eclampsia via regulation of Notch2.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31643078","citation_count":19,"is_preprint":false},{"pmid":"29329397","id":"PMC_29329397","title":"MINAR1 is a Notch2-binding protein that inhibits angiogenesis and breast cancer growth.","date":"2018","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/29329397","citation_count":18,"is_preprint":false},{"pmid":"33712887","id":"PMC_33712887","title":"LncRNA LINC01410 Induced by MYC Accelerates Glioma Progression via Sponging miR-506-3p and Modulating NOTCH2 Expression to Motivate Notch Signaling Pathway.","date":"2021","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/33712887","citation_count":18,"is_preprint":false},{"pmid":"28666642","id":"PMC_28666642","title":"Pathobiology of Notch2 in lung cancer.","date":"2017","source":"Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28666642","citation_count":17,"is_preprint":false},{"pmid":"33214146","id":"PMC_33214146","title":"TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33214146","citation_count":17,"is_preprint":false},{"pmid":"26427670","id":"PMC_26427670","title":"Notch2 signaling contributes to cell growth, invasion, and migration in salivary adenoid cystic carcinoma.","date":"2015","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26427670","citation_count":17,"is_preprint":false},{"pmid":"34821000","id":"PMC_34821000","title":"MicroRNA-181a restricts human γδ T cell differentiation by targeting Map3k2 and Notch2.","date":"2021","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/34821000","citation_count":16,"is_preprint":false},{"pmid":"34245196","id":"PMC_34245196","title":"CARMN-NOTCH2 fusion transcript drives high NOTCH2 expression in glomus tumors of the upper digestive tract.","date":"2021","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34245196","citation_count":16,"is_preprint":false},{"pmid":"26640406","id":"PMC_26640406","title":"Effects of Notch2 and Notch3 on Cell Proliferation and Apoptosis of Trophoblast Cell Lines.","date":"2015","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26640406","citation_count":16,"is_preprint":false},{"pmid":"35699595","id":"PMC_35699595","title":"RNF144B stimulates the proliferation and inhibits the apoptosis of human spermatogonial stem cells via the FCER2/NOTCH2/HES1 pathway and its abnormality is associated with azoospermia.","date":"2022","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35699595","citation_count":16,"is_preprint":false},{"pmid":"31992595","id":"PMC_31992595","title":"Antisense oligonucleotides targeting Notch2 ameliorate the osteopenic phenotype in a mouse model of Hajdu-Cheney syndrome.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31992595","citation_count":16,"is_preprint":false},{"pmid":"38438375","id":"PMC_38438375","title":"Notch2 controls developmental fate choices between germinal center and marginal zone B cells upon immunization.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38438375","citation_count":15,"is_preprint":false},{"pmid":"39601111","id":"PMC_39601111","title":"Targeting the NOTCH2/ADAM10/TCF7L2 Axis-Mediated Transcriptional Regulation of Wnt Pathway Suppresses Tumor Growth and Enhances Chemosensitivity in Colorectal Cancer.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39601111","citation_count":14,"is_preprint":false},{"pmid":"28606936","id":"PMC_28606936","title":"Notch2 and Notch3 suppress the proliferation and mediate invasion of trophoblast cell lines.","date":"2017","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/28606936","citation_count":14,"is_preprint":false},{"pmid":"31659254","id":"PMC_31659254","title":"ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31659254","citation_count":14,"is_preprint":false},{"pmid":"34635817","id":"PMC_34635817","title":"Gm364 coordinates MIB2/DLL3/Notch2 to regulate female fertility through AKT activation.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/34635817","citation_count":14,"is_preprint":false},{"pmid":"36574342","id":"PMC_36574342","title":"The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell-mediated graft-versus-host disease.","date":"2023","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/36574342","citation_count":13,"is_preprint":false},{"pmid":"37607223","id":"PMC_37607223","title":"Bcl6, Irf2, and Notch2 promote nonclassical monocyte development.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37607223","citation_count":12,"is_preprint":false},{"pmid":"22695918","id":"PMC_22695918","title":"Notch2 and immune function.","date":"2012","source":"Current topics in microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22695918","citation_count":11,"is_preprint":false},{"pmid":"38159855","id":"PMC_38159855","title":"NOTCH2 promotes osteoclast maturation and metabolism and modulates the transcriptome profile during osteoclastogenesis.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38159855","citation_count":11,"is_preprint":false},{"pmid":"33382997","id":"PMC_33382997","title":"High expression of Notch2 drives tongue squamous cell carcinoma carcinogenesis.","date":"2020","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33382997","citation_count":11,"is_preprint":false},{"pmid":"29853569","id":"PMC_29853569","title":"Notch2 and Proteomic Signatures in Mouse Neointimal Lesion Formation.","date":"2018","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29853569","citation_count":11,"is_preprint":false},{"pmid":"31891282","id":"PMC_31891282","title":"Post-treatment curcumin reduced ischemia-reperfusion-induced pulmonary injury via the Notch2/Hes-1 pathway.","date":"2019","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/31891282","citation_count":11,"is_preprint":false},{"pmid":"36153188","id":"PMC_36153188","title":"Expression profiling of inflammation-related genes including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 patients.","date":"2022","source":"Biologicals : journal of the International Association of Biological Standardization","url":"https://pubmed.ncbi.nlm.nih.gov/36153188","citation_count":11,"is_preprint":false},{"pmid":"37865314","id":"PMC_37865314","title":"NOTCH2 sensitizes the chondrocyte to the inflammatory response of tumor necrosis factor α.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37865314","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49539,"output_tokens":10531,"usd":0.153291,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":21268,"output_tokens":5818,"usd":0.125895,"stage2_stop_reason":"end_turn"},"total_usd":0.279186,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"NOTCH2 encodes a second mammalian Notch receptor containing all structural motifs characteristic of Notch proteins (EGF-like repeats, transmembrane domain, ankyrin repeats), establishing it as a paralog of Drosophila Notch with distinct spatial and temporal expression patterns from Notch1.\",\n      \"method\": \"cDNA cloning, Northern blot, in situ hybridization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — structural identification by cloning with expression profiling; single lab but multiple methods establishing identity and non-redundancy with Notch1\",\n      \"pmids\": [\"1295745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The ankyrin repeats in the cytoplasmic domain of Notch2 are indispensable for its function; mice homozygous for a Notch2 mutation replacing ankyrin repeats die before E11.5 with increased apoptosis in neural tissues, while somitogenesis and neurogenic gene regulation (Hes-5, Mash1) are unaffected, distinguishing Notch2 from Notch1 functionally.\",\n      \"method\": \"Gene targeting (knock-in of beta-galactosidase replacing ankyrin repeats), X-gal staining, in situ hybridization, TUNEL assay\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic loss-of-function with precise domain disruption, multiple phenotypic readouts, comparison to Notch1 knockout in same study\",\n      \"pmids\": [\"10393120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The intracellular domains of Notch1, Notch2, and Notch3 have distinct and non-equivalent transcriptional activities on HES1 and HES5 promoters; Notch2 ICD can suppress the transcriptional activities of Notch1 and Notch3 ICDs in a dose-dependent and promoter-dependent manner, and activity depends on RBP-Jκ expression levels.\",\n      \"method\": \"Luciferase reporter assay using HES1-Luc and HES5-Luc constructs, transfection of truncated ICD forms, co-expression experiments\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro transcriptional assays with defined constructs; single lab, single method type\",\n      \"pmids\": [\"11866432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Constitutively activated Notch2 in pre-gonadotrope and pre-thyrotrope cells delays gonadotrope differentiation, with Hey1 as a candidate mediator; gonadotrope differentiation eventually completes but is mutually exclusive with Notch2 transgene expression, demonstrating that activated Notch2 is sufficient to delay pituitary progenitor differentiation.\",\n      \"method\": \"Transgenic mice expressing activated NOTCH2 ICD under alphaGSU promoter, histology, immunostaining for LH/FSH/Hey1\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function transgenic model with defined cellular phenotype and candidate downstream mediator (Hey1); single lab\",\n      \"pmids\": [\"16840533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Notch2 ICD expression induces apoptosis in MDA-MB-231 breast adenocarcinoma cells and potently suppresses tumor xenograft growth in vivo, demonstrating a tumor-suppressive role distinct from the oncogenic Notch4 ICD in this context.\",\n      \"method\": \"Stable ICD expression, in vitro apoptosis assays, nude mouse xenograft tumor growth assay\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with both in vitro and in vivo phenotypic readouts; single lab\",\n      \"pmids\": [\"17675579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RANKL induces expression of Jagged1 and Notch2 in bone marrow macrophages during osteoclastogenesis; Notch2 ICD and p65 (NF-κB) physically interact in the nucleus of RANKL-stimulated cells and are co-recruited to the NFATc1 promoter, driving NFATc1 expression and osteoclast differentiation.\",\n      \"method\": \"shRNA knockdown, gamma-secretase inhibitor, ectopic Notch2 ICD expression, luciferase reporter assay, Co-immunoprecipitation, chromatin immunoprecipitation (ChIP)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (Co-IP, ChIP, reporter assay, knockdown, overexpression) in a single study establishing molecular mechanism\",\n      \"pmids\": [\"18710934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SCF (stem cell factor) signaling induces upregulation of Notch2 in primary human erythroblasts; functional inhibition of Notch or Jagged1 blocks SCF-mediated erythroid expansion, and dominant-negative Notch2 inhibits both basal and SCF-mediated erythroblast expansion while counteracting SCF-mediated delay of differentiation. SCF also induces Hes-1 and GATA-2 downstream of Notch2.\",\n      \"method\": \"Primary human erythroblast culture, dominant-negative Notch2 retroviral transduction, Notch/Jagged1 inhibitory antibodies, gene expression analysis\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional inhibition and dominant-negative approaches with defined phenotype; single lab, multiple methods\",\n      \"pmids\": [\"20829885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Constitutive activation of Notch2 in Six2-positive nephron progenitor cells of the metanephric mesenchyme depletes the progenitor pool through ectopic Wnt4 expression and premature tubule formation, and suppresses Pax2 possibly through Hesr genes, revealing a positive feedback loop between Notch2 and Wnt4 in which Notch2 stabilizes nephron fate by shutting down progenitor maintenance.\",\n      \"method\": \"Conditional Notch2 gain-of-function mouse (Six2-Cre), histology, in situ hybridization, gene expression analysis\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional gain-of-function in vivo with defined cellular and molecular phenotype; single lab\",\n      \"pmids\": [\"20299358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DC-specific deletion of Notch2 ablates the Esam(hi) CD11b+ DC subset in the spleen (which requires lymphotoxin beta receptor signaling and facilitates CD4+ T cell priming) and eliminates CD11b+CD103+ DCs in the intestinal lamina propria, demonstrating that Notch2 is a common differentiation signal for T cell-priming CD11b+ DC subsets.\",\n      \"method\": \"DC-specific Notch2 conditional knockout mice, flow cytometry, T cell priming assays, in vivo lymphotoxin beta receptor signaling analysis\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with multiple tissue readouts, functional T cell priming assays; replicated in multiple tissues\",\n      \"pmids\": [\"22018469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Conditional deletion of Notch2 in the ocular lens causes microphthalmia, persistent lens stalks, disrupted fiber cell morphology, aberrant DNA synthesis in fiber cells, denucleation defects, and cataracts; loss of Notch2 elevates Cdkn1a (p21), CyclinD2, and p63 while downregulating E-Cadherin, demonstrating roles for Notch2 in lens morphogenesis, apoptosis suppression, cell cycle withdrawal, and secondary fiber cell differentiation.\",\n      \"method\": \"Conditional Notch2 knockout (lens-specific Cre), histology, immunostaining, gene expression analysis, BrdU labeling\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific conditional knockout with multiple phenotypic and molecular readouts in a single rigorous study\",\n      \"pmids\": [\"22173065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Functional analysis of NOTCH2 missense, nonsense, and splicing mutations found in Alagille syndrome patients demonstrated decreased Notch signaling activity for these variants, establishing loss-of-function as the molecular mechanism underlying NOTCH2-associated Alagille syndrome.\",\n      \"method\": \"Cell-based Notch signaling reporter assays for six patient-derived NOTCH2 mutations\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — functional signaling assays on multiple alleles; single lab\",\n      \"pmids\": [\"22209762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Proteolytic activation of NOTCH2 requires sequential cleavage by ADAM10 metalloprotease and presenilin-1 or -2 (gamma-secretase) upon canonical Delta/Jagged ligand binding; ADAM17/TACE is not required for ligand-induced NOTCH2 signaling, establishing that NOTCH1, -2, and -3 share a common ADAM10-dependent activation mechanism.\",\n      \"method\": \"Notch signaling assays with ADAM10/ADAM17/presenilin knockout or inhibitor conditions, NOTCH2 cleavage assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical and functional dissection of proteolytic activation with multiple enzyme knockouts/inhibitors and multiple Notch paralogs compared\",\n      \"pmids\": [\"24842903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Notch2 ICD-specific activation of Akt signaling protects podocytes from apoptosis; a Notch2 agonistic antibody ameliorates proteinuria and glomerulosclerosis in a nephrosis mouse model, and this protective effect is abolished by the Akt inhibitor triciribine, placing Notch2 upstream of Akt in podocyte survival.\",\n      \"method\": \"Notch2 agonistic monoclonal antibody in vivo, Notch2 siRNA knockdown in vitro, Akt inhibitor rescue experiment, mouse nephrosis model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro and in vivo experiments with pharmacological and genetic tools establishing Notch2→Akt pathway in podocytes\",\n      \"pmids\": [\"24526233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Notch2 deletion in a KrasG12D-driven NSCLC mouse model dramatically increases carcinogenesis and accelerates death; Notch2-deficient tumors show increased beta-catenin expression, undifferentiated phenotype, and aggressive growth, while Notch1 regulates MAPK via HES1-DUSP1. Notch2 and Notch1 have opposing roles: Notch2 mediates differentiation and tumor suppression, Notch1 promotes tumor initiation.\",\n      \"method\": \"Conditional Notch1 and Notch2 receptor deletion in KrasG12D endogenous NSCLC mouse model, tumor morphometry, IHC, gene expression\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout in established endogenous cancer model with mechanistic pathway analysis; in vivo with histological and molecular validation\",\n      \"pmids\": [\"24509876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Swapping the intracellular domains of Notch1 and Notch2 in mice shows their ICDs are functionally equivalent; differences in developmental outcomes between Notch1 and Notch2 are explained by differences in signal strength (number of ICD molecules reaching the nucleus) and duration (half-life of NICD-RBPjk-MAML-DNA complexes), with tissue-specific gamma-secretase complexes contributing to differential NICD stability.\",\n      \"method\": \"Knock-in ICD swap mice, T-cell development assays, skin differentiation, inner ear, lung, retina phenotyping; epistasis analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — rigorous genetic epistasis using ICD swap knock-in mice across multiple tissue contexts with mechanistic interpretation\",\n      \"pmids\": [\"26062937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Human NOTCH2 is resistant to ligand-independent activation by ADAM17 (TACE), unlike human NOTCH1 and murine Notch2, which both require ADAM17 for ligand-independent signaling; this reveals subtle but functionally important differences in the negative regulatory region (NRR) between NOTCH paralogs and between human and murine NOTCH2.\",\n      \"method\": \"Biochemical cleavage assays, cell-based Notch signaling assays, comparison of human vs. murine Notch1/Notch2 NRR\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — rigorous biochemical and functional comparison of human vs. murine receptors with multiple assays in a single focused study\",\n      \"pmids\": [\"25918160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Simultaneous loss of Notch2 and Notch3 in vascular smooth muscle cells causes patent ductus arteriosus (PDA), aortic dilation, and subcutaneous hemorrhage, associated with decreased expression of smooth muscle contractile markers; these receptors have overlapping roles in vascular smooth muscle differentiation.\",\n      \"method\": \"Smooth muscle-specific Notch2 conditional knockout combined with global Notch3 deletion, vascular morphology analysis, IHC for contractile markers\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis via combined knockout with defined vascular phenotype and molecular markers; single lab\",\n      \"pmids\": [\"26453897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Notch2 blockade (but not Notch1 blockade) sensitizes hematopoietic stem/progenitor cells (HSPCs) to mobilization stimuli and promotes their egress from marrow; Notch2 loss decreases CXCR4 expression on HSCs through direct regulation of CXCR4 transcription by the Notch transcriptional protein RBPJ.\",\n      \"method\": \"Notch receptor-blocking antibodies in vivo, conditional Notch2 knockout mice, flow cytometry, CXCR4 expression analysis, ChIP for RBPJ on CXCR4 promoter\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — antibody blockade, genetic knockout, and ChIP demonstrating direct transcriptional regulation; multiple orthogonal methods\",\n      \"pmids\": [\"28729299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Notch2, but not Notch1, conveys quiescence to ventricular-subventricular zone (V-SVZ) neural stem cells (NSCs) by repressing cell-cycle-related genes and neurogenesis; loss of Notch2 activates quiescent NSCs leading to accelerated exhaustion and an aging-like phenotype.\",\n      \"method\": \"Conditional Notch2 knockout mice (V-SVZ NSC-specific), BrdU/EdU labeling, gene expression analysis, comparison with Notch1 and Rbpj knockouts\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with clear quiescence phenotype, comparison across Notch paralogs and canonical signaling\",\n      \"pmids\": [\"29386140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Notch2 is the primary determinant of hepatocyte-derived intrahepatic cholangiocarcinoma (ICC) formation; deletion of Notch2 (but not Notch1) in AKT/Yap-induced tumors switches phenotype from ICC to hepatocellular adenoma-like lesions, and Notch2 silencing in ICC cell lines downregulates the biliary markers Sox9 and EpCAM.\",\n      \"method\": \"Notch1/Notch2 conditional knockout mice, AKT/Yap hydrodynamic injection model, lineage tracing, siRNA knockdown in human ICC/HCC lines, Western blot\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockouts with lineage tracing and in vitro validation; two complementary genetic approaches\",\n      \"pmids\": [\"29545603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Jagged1/Notch2 signaling in renal tubular epithelial cells drives kidney fibrosis by directly targeting the mitochondrial transcription factor Tfam; re-expression of Tfam prevents Notch-induced metabolic and profibrotic reprogramming; tubule-specific deletion of Jag1 or Notch2 (but not Notch1 or Notch3) protects from folic acid-induced nephropathy.\",\n      \"method\": \"Tubule-specific Jag1 and Notch2 conditional knockout mice, folic acid nephropathy model, ChIP for Notch target on Tfam promoter, genome-wide expression studies, Tfam re-expression rescue\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — conditional knockouts, ChIP establishing direct target, genome-wide expression, and rescue experiment; multiple orthogonal methods\",\n      \"pmids\": [\"30226866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MINAR1 (KIAA1024/UPF0258) physically interacts with Notch2, increases its stability and signaling function, and negatively regulates angiogenesis; MINAR1 is a large intrinsically disordered protein with a single transmembrane domain expressed in breast epithelial and endothelial cells.\",\n      \"method\": \"Co-immunoprecipitation, pulldown, angiogenesis assays (cell culture, matrigel plug, zebrafish model), breast cancer xenograft model\",\n      \"journal\": \"Journal of molecular cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishing physical interaction plus functional in vitro and in vivo angiogenesis assays; single lab\",\n      \"pmids\": [\"29329397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Id4 is a direct downstream target of Notch2 signaling in hippocampal dentate gyrus NSCs and maintains quiescence by blocking cell-cycle entry; Id4 expression is sufficient to promote NSC quiescence, Id4 knockdown rescues Notch2-induced inhibition of NSC proliferation, establishing a Notch2-Id4 axis that uncouples NSC activation from neuronal differentiation.\",\n      \"method\": \"Conditional Notch2 knockout, Id4 knockout and overexpression mice, lentiviral Id4 knockdown, BrdU labeling, gene expression analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with rescue experiment establishing Notch2→Id4 pathway; multiple orthogonal genetic tools\",\n      \"pmids\": [\"31390563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NOTCH2 intracellular domain (N2ICD) interacts with TRAF6 via immunoprecipitation, attenuating the TRAF6-AKT signaling axis to inhibit epithelial-mesenchymal transition (EMT) and suppress metastasis in nasopharyngeal carcinoma.\",\n      \"method\": \"Immunoprecipitation, Western blot, cell migration/invasion assays, mouse tumor metastasis models, GSEA\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP establishing N2ICD-TRAF6 interaction plus functional validation in vitro and in vivo; single lab\",\n      \"pmids\": [\"31699119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Fringe enzymes differentially modulate NOTCH2 vs. NOTCH1: Lunatic fringe (LFNG) enhances NOTCH2 activation by DLL1/DLL4 through O-fucosylation on EGF8 and EGF12, while Manic fringe (MFNG) inhibits NOTCH2 activation by JAG1/JAG2; a single O-fucose site mutant blocking MFNG inhibition of NOTCH2-JAG1 signaling was not identifiable (unlike NOTCH1). O-fucosylation on EGF9 is important for trafficking of both NOTCH1 and NOTCH2.\",\n      \"method\": \"Cell-based Notch signaling assays, ligand-binding assays, mass spectrometry (O-fucose site mapping), site-directed mutagenesis of O-fucose sites\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mass spectrometry mapping plus site-directed mutagenesis plus functional signaling assays; multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"32820046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DTX3 (Deltex E3 ubiquitin ligase 3) is a novel E3 ligase for NOTCH2; DTX3 promotes ubiquitination and proteasome-dependent degradation of NOTCH2, and DTX3 overexpression suppresses esophageal carcinoma cell proliferation and tumorigenicity.\",\n      \"method\": \"Yeast two-hybrid screening, Co-immunoprecipitation, ubiquitination assay, proteasome inhibitor experiments, overexpression/knockdown functional assays\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Y2H identification confirmed by Co-IP and ubiquitination assay with functional consequences; single lab\",\n      \"pmids\": [\"31854042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CAFs-derived MFAP5 promotes bladder cancer by directly interacting with the NOTCH2 receptor to stimulate N2ICD release, activating the NOTCH2/HEY1 signaling pathway; DLL4/NOTCH2 pathway activation also mediates MFAP5 effects via PI3K-AKT signaling.\",\n      \"method\": \"Luciferase reporter assay, EMSA, Co-immunoprecipitation, shRNA knockdown, anti-NOTCH2 antibody (NRR2Mab), RNA-sequencing, in vivo xenograft\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction demonstrated by Co-IP and functional downstream activation by multiple assays; single lab\",\n      \"pmids\": [\"32293074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The DLL1-NOTCH2 ligand-receptor pair is required for satellite cell self-renewal during muscle regeneration; differentiating satellite cells expressing Dll1 signal via NOTCH2 to neighboring cells to maintain the progenitor pool in a proportional feedback mechanism.\",\n      \"method\": \"Single-cell RNA-sequencing (identifying Notch2-enriched satellite cell subpopulation), antagonistic antibodies against DLL1 and NOTCH2, in vivo muscle regeneration assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — scRNA-seq identification followed by antibody-based functional validation in vivo; multiple methods\",\n      \"pmids\": [\"32023464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Induced Notch2 ICD expression in mature follicular B (FoB) cells reprograms them into bona fide marginal zone B (MZB) cells (surface phenotype, localization, immunological function, transcriptome), demonstrating plasticity between mature B cell populations driven by a singular Notch2 signaling event.\",\n      \"method\": \"Inducible Notch2IC expression in FoB cells in immunocompetent mice, flow cytometry, transcriptome analysis, localization and functional assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — inducible gain-of-function in mature cells with comprehensive phenotypic, transcriptomic, and functional characterization\",\n      \"pmids\": [\"33597542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CARM1 (coactivator-associated arginine methyltransferase 1) is recruited to the nucleus by Nup54, where it cooperates with TFEB to activate Notch2 transcription by inducing H3R17me2 (but not H3R26me2) at the Notch2 promoter; CARM1 also methylates the Notch2 ICD (N2ICD) at R1786, R1838, and R2047, which enhances N2ICD binding to MAML1 and promotes gastric cancer cell proliferation.\",\n      \"method\": \"ChIP-seq, RNA-seq, Co-IP (Nup54-CARM1 and N2ICD-MAML1 interactions), site-directed mutagenesis of N2ICD methylation sites, in vitro and in vivo proliferation assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — ChIP-seq, mutagenesis of modification sites, Co-IP of downstream complex, and functional rescue; multiple orthogonal methods\",\n      \"pmids\": [\"34725461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The deubiquitinase OTUD1 interacts with Notch2-ICD (NICD) and cleaves ubiquitin from NICD at the K1770 site, thereby stabilizing NICD protein in activated CD4+ T cells and promoting Th1/Th17 differentiation and graft-versus-host disease.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, site-specific K1770 deubiquitination, conditional knockout mice, GVHD model, FDA-approved drug screen\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-specific deubiquitination at K1770 established by biochemical assay, Co-IP, and in vivo functional validation\",\n      \"pmids\": [\"36574342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FCER2 pulls down N2ICD (NOTCH2 intracellular domain) and N2ICD binds FCER2 in human spermatogonial stem cells (SSCs); the RNF144B-FCER2-NOTCH2/HES1 pathway regulates SSC proliferation and survival.\",\n      \"method\": \"Co-immunoprecipitation (RNF144B-FCER2; FCER2-N2ICD), RNA sequencing, siRNA/overexpression functional assays\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP establishing FCER2-N2ICD interaction with functional pathway validation; single lab\",\n      \"pmids\": [\"35699595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Notch2 signaling directly promotes FOXP3 transcription and Treg cell differentiation in human CD4+ T cells in vitro; in an allergic rhinitis mouse model, Notch2 overexpression increased Treg cell differentiation and reduced allergic inflammation.\",\n      \"method\": \"In vitro human CD4+ T cell differentiation assay, luciferase reporter for FOXP3 transcription, lentiviral Notch2 overexpression in AR mouse model, flow cytometry for Treg cells\",\n      \"journal\": \"Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay establishing direct FOXP3 transcriptional activation, plus in vivo validation; single lab\",\n      \"pmids\": [\"34480930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In skeletal muscle, multinucleated myofibers express Notch2, which is activated by endothelium-derived Dll4 released without direct cell-cell contact under atrophic conditions (disuse or diabetes); inhibition of the Dll4-Notch2 axis prevents muscle atrophy and promotes hypertrophy in mice.\",\n      \"method\": \"Conditional Notch2 knockout in myofibers, Dll4/Notch2 inhibitory antibodies, mouse models of disuse and diabetic atrophy and mechanical overload-induced hypertrophy, molecular analysis\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout and antibody blockade in multiple physiological and pathological in vivo models; replication across atrophy conditions\",\n      \"pmids\": [\"35228746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KLHL6 is a novel E3 ubiquitin ligase that targets plasma membrane-associated NOTCH2 for proteasome-dependent degradation; DLBCL-associated NOTCH2 mutations cause protein escape from this KLHL6-mediated ubiquitin-dependent proteolysis, leading to NOTCH2 stabilization and activation of oncogenic RAS signaling in chemoresistant tumors.\",\n      \"method\": \"CRISPR-Cas9 cullin-RING ligase library screen, proteomic approaches identifying KLHL6-NOTCH2 interaction, ubiquitination assays, pharmacological rescue with gamma-secretase inhibitor and AKT inhibitor\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — CRISPR screen, proteomics, ubiquitination assays, and pharmacological rescue establishing the KLHL6-NOTCH2 degradation axis\",\n      \"pmids\": [\"37235754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DLL1-induced NOTCH2 signaling efficiently induces the transition of Ly6Chi TREML4- monocytes into Ly6Clo TREML4+ nonclassical monocytes in vitro; this transition requires IRF2 but can occur without NUR77 or BCL6, establishing a transcriptional hierarchy downstream of Notch2 in monocyte development.\",\n      \"method\": \"In vitro DLL1-driven Notch2 activation, myeloid-specific BCL6/IRF2 knockout mice, flow cytometry for monocyte subset phenotype\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro Notch2 activation combined with genetic epistasis; single lab\",\n      \"pmids\": [\"37607223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A pan-cancer tRNA-derived fragment CAT1 binds RBPMS and displaces NOTCH2 mRNA from RBPMS, thereby inhibiting CCR4-NOT deadenylation complex-mediated NOTCH2 mRNA decay and stabilizing NOTCH2 mRNA to promote lung cancer proliferation and metastasis.\",\n      \"method\": \"RNA pulldown, RIP assay, NOTCH2 mRNA stability assay, CAT1 overexpression/knockdown in vitro and in vivo\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA pulldown and RIP establishing CAT1-RBPMS-NOTCH2 mRNA interaction with functional validation; single lab\",\n      \"pmids\": [\"37943661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NOTCH2 gain-of-function enhances osteoclastogenesis by upregulating cell metabolism, aerobic respiration, and mitochondrial function in osteoclast progenitors; these pathways are not enhanced in the context of Hes1 inactivation, placing Hes1 as an obligate mediator of NOTCH2-driven osteoclast metabolic enhancement.\",\n      \"method\": \"Bulk RNA-seq, single-cell RNA-seq, pseudotime trajectory analysis of Notch2 gain-of-function (Notch2tm1.1Ecan) and Hes1-conditional knockout bone marrow macrophages\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-seq and scRNA-seq with genetic epistasis establishing Hes1-dependency; single lab\",\n      \"pmids\": [\"38159855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NOTCH2 gain-of-function enhances TNFα-induced Il6 and Il1b expression in chondrocytes; TNFα displaces RBPJκ from DNA binding sites (demonstrated by EMSA), explaining both increased Il6 expression and concomitant decrease in canonical Notch target genes Hes1/Hey1/Hey2/Heyl. NOTCH2 also enhances TNFα-activated NF-κB signaling.\",\n      \"method\": \"Notch2 gain-of-function mouse chondrocytes (Notch2tm1.1Ecan), NOTCH2-ICD overexpression, EMSA for RBPJκ DNA binding, RNA-seq, NF-κB signaling assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — EMSA establishing displacement mechanism, RNA-seq, multiple genetic and overexpression models, and pharmacological analysis\",\n      \"pmids\": [\"37865314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NOTCH2 mediates immune escape in hepatocellular carcinoma by NETs-activated NF-κB pathway upregulating CD73, which promotes regulatory T cell infiltration; DNase I inhibition of NETs reduces this NOTCH2-mediated CD73 upregulation.\",\n      \"method\": \"In vitro NETs stimulation, NOTCH2 pathway analysis, CD73 expression assays, mouse HCC model by hydrodynamic plasmid transfection, anti-PD-1 combination experiments\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo mechanistic experiments; single lab with multiple assays\",\n      \"pmids\": [\"38969159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Notch2 signaling controls the fate decision between germinal center (GC) B cells and marginal zone B (MZB) cells upon immunization: antigen-activated FoB cells that turn off Notch2 signaling enter GCs, while high Notch2 signaling drives MZB cell generation or plasmablast differentiation; mathematical modeling supports a binary Notch2-dependent fate decision.\",\n      \"method\": \"Conditional Notch2 ablation and constitutive activation in B cells during T-cell-dependent immunization, flow cytometry for B cell subsets, mathematical modeling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complementary gain- and loss-of-function genetic models in vivo with quantitative modeling; replicates and extends prior work on Notch2 in B cell fate\",\n      \"pmids\": [\"38438375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ADAM10 regulates NOTCH2 protein expression in colorectal cancer; the NOTCH2 ICD directly activates TCF7L2 transcription and Wnt target genes (MYC, JUN, CCND1/2) without directly interacting with TCF7L2 protein, establishing a NOTCH2-mediated transcriptional regulation of the Wnt pathway axis.\",\n      \"method\": \"High-throughput organoid drug screening, ADAM10 knockdown/inhibition, NOTCH2 and TCF7L2 Co-IP (negative for direct interaction), ChIP or transcriptional reporter assays for TCF7L2 regulation\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — organoid screening combined with mechanistic dissection; negative Co-IP (no direct NOTCH2-TCF7L2 interaction) is a negative result; transcriptional activation is supported; single lab\",\n      \"pmids\": [\"39601111\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NOTCH2 is a type I transmembrane receptor activated by sequential ADAM10- and gamma-secretase (presenilin)-mediated proteolysis upon binding Delta-like or Jagged ligands, releasing the ICD (N2ICD) that forms a transcriptional activation complex with RBPJκ and MAML1 to drive HES/HEY target gene expression; its signaling strength and duration (governed by tissue-specific gamma-secretase activity and post-translational modifications including O-fucosylation by Fringe enzymes, arginine methylation by CARM1, and ubiquitination/deubiquitination by KLHL6/DTX3/OTUD1) determines cell fate outcomes across diverse contexts including DC differentiation, B cell MZB vs. GC fate decisions, neural stem cell quiescence, osteoclastogenesis, kidney fibrosis, nephron development, muscle mass regulation, and tumor suppression or promotion depending on cell type.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NOTCH2 is a type I transmembrane receptor that converts ligand engagement into transcriptional output to control cell-fate decisions across developmental, immune, skeletal, and oncogenic contexts [#0, #14]. Productive signaling requires sequential proteolysis: upon Delta-like/Jagged ligand binding, ADAM10 (not ADAM17) and presenilin-dependent gamma-secretase cleave the receptor to release the intracellular domain (N2ICD), which enters the nucleus and assembles with RBPJ\\u03ba and MAML1 to drive HES/HEY target gene transcription [#11, #29]. Ligand selectivity and signal strength are tuned at the cell surface by Fringe-mediated O-fucosylation, where Lunatic fringe enhances DLL1/DLL4-driven activation and Manic fringe restrains Jagged-driven activation [#24], and human NOTCH2 is distinguished from NOTCH1 and murine Notch2 by resistance to ligand-independent ADAM17 cleavage [#15]; ICD-swap experiments establish that the NOTCH1 and NOTCH2 ICDs are intrinsically equivalent, so paralog-specific outcomes reflect differences in signal strength and N2ICD duration set by tissue-specific gamma-secretase [#14]. N2ICD abundance is further governed post-translationally by E3 ligases KLHL6 and DTX3, the deubiquitinase OTUD1 (acting at K1770), and arginine methylation by CARM1 that strengthens N2ICD\\u2013MAML1 binding [#34, #25, #30, #29]. Through this machinery NOTCH2 directs nephron progenitor and lens differentiation [#7, #9], drives CD11b+ dendritic cell and marginal-zone vs. germinal-center B cell fate decisions [#8, #28, #40], imposes quiescence on neural stem cells via an Id4 axis [#18, #22], promotes osteoclastogenesis through NF-\\u03baB/NFATc1 [#5, #37], and regulates muscle mass via an endothelial Dll4\\u2013Notch2 axis [#33]. In cancer it is context-dependent, acting as a differentiation-promoting tumor suppressor in lung and breast models while being stabilized by oncogenic mutation in lymphoma [#13, #4, #34]. Loss-of-function NOTCH2 mutations that reduce signaling cause Alagille syndrome [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Establishing NOTCH2 as a distinct mammalian Notch paralog defined the receptor as a candidate fate-determining molecule with its own expression domains rather than a redundant copy of Notch1.\",\n      \"evidence\": \"cDNA cloning with Northern blot and in situ hybridization expression profiling\",\n      \"pmids\": [\"1295745\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional or signaling mechanism defined\", \"Ligand and downstream targets unknown at this stage\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Genetic disruption of the cytoplasmic ankyrin repeats showed they are indispensable and that Notch2 has non-redundant functions distinct from Notch1, framing the ICD as the functional effector.\",\n      \"evidence\": \"Knock-in gene targeting replacing ankyrin repeats in mice, with TUNEL and in situ readouts\",\n      \"pmids\": [\"10393120\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which downstream complex the ankyrin repeats engage\", \"Embryonic lethality limited tissue-specific analysis\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Comparing ICD transcriptional activities revealed paralog-specific, RBPJ\\u03ba-dependent effects on HES promoters, raising the question of how paralog identity translates into distinct outputs.\",\n      \"evidence\": \"Luciferase reporter assays on HES1/HES5 promoters with truncated ICD constructs\",\n      \"pmids\": [\"11866432\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro overexpression may not reflect physiological stoichiometry\", \"Cross-suppression mechanism not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defining the Notch2 ICD\\u2013p65 interaction at the NFATc1 promoter established a concrete molecular mechanism coupling Notch2 to NF-\\u03baB during osteoclastogenesis.\",\n      \"evidence\": \"Co-IP, ChIP, reporter assays, knockdown and ICD overexpression in bone marrow macrophages\",\n      \"pmids\": [\"18710934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NF-\\u03baB cooperation generalizes beyond osteoclasts unclear at the time\", \"Direct contact surface between N2ICD and p65 not mapped\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Tissue-specific knockouts established non-redundant Notch2 roles in dendritic cell differentiation and lens morphogenesis, moving the receptor from candidate to validated fate determinant in defined cell types.\",\n      \"evidence\": \"DC-specific and lens-specific conditional knockout mice with flow cytometry, T cell priming assays, histology and gene expression\",\n      \"pmids\": [\"22018469\", \"22173065\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets in these tissues not fully defined\", \"Ligand source driving activation in vivo not always identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that Alagille-associated NOTCH2 variants reduce signaling established loss-of-function as the disease mechanism, linking quantitative signaling output to human pathology.\",\n      \"evidence\": \"Cell-based Notch reporter assays on six patient-derived NOTCH2 mutations\",\n      \"pmids\": [\"22209762\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Tissue-level consequences of partial signaling loss not modeled\", \"Single assay system for diverse mutation types\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Dissecting the proteolytic cascade established that NOTCH2 activation depends on ADAM10 and presenilin gamma-secretase but not ADAM17, defining the canonical activation route shared with other Notch paralogs.\",\n      \"evidence\": \"Notch signaling and cleavage assays under ADAM10/ADAM17/presenilin knockout or inhibitor conditions\",\n      \"pmids\": [\"24842903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address ligand-independent activation differences between species\", \"Spatial site of cleavage not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Knockouts in cancer and kidney models revealed that Notch2 can act as a tumor suppressor promoting differentiation and can signal to Akt for podocyte survival, expanding its functions beyond canonical HES transcription.\",\n      \"evidence\": \"Conditional Notch2 deletion in KrasG12D NSCLC model; Notch2 agonist antibody plus Akt inhibitor rescue in nephrosis model\",\n      \"pmids\": [\"24509876\", \"24526233\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking N2ICD to Akt not biochemically defined\", \"Cell-type basis of tumor suppressor vs. oncogenic switch unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"ICD-swap and NRR comparison experiments resolved why paralogs differ: the ICDs are intrinsically equivalent and outcomes depend on signal strength, ICD duration, and species/paralog-specific regulatory regions.\",\n      \"evidence\": \"Knock-in ICD-swap mice across multiple tissues; biochemical NRR comparison of human vs. murine Notch1/Notch2\",\n      \"pmids\": [\"26062937\", \"25918160\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular determinants setting tissue-specific gamma-secretase activity not identified\", \"Quantitative ICD thresholds for fate decisions not measured\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Multiple in vivo studies established Notch2 as a controller of stem cell quiescence and lineage selection, with a defined Notch2\\u2192Id4 axis and direct profibrotic targeting of Tfam, showing how the receptor reprograms differentiation and metabolism.\",\n      \"evidence\": \"Conditional knockouts in V-SVZ NSCs and renal tubular epithelium; ChIP on Tfam promoter; Tfam rescue; later Id4 epistasis with rescue\",\n      \"pmids\": [\"29386140\", \"30226866\", \"31390563\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Notch2 selects quiescence vs. proliferation programs not fully defined\", \"Direct vs. indirect target relationships vary by tissue\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identifying Fringe-mediated O-fucosylation and E3 ligase DTX3 control established two layers\\u2014glycosylation and ubiquitin-dependent degradation\\u2014that tune NOTCH2 ligand selectivity and abundance.\",\n      \"evidence\": \"Mass spectrometry O-fucose site mapping with mutagenesis and signaling assays; Y2H, Co-IP and ubiquitination assays for DTX3\",\n      \"pmids\": [\"32820046\", \"31854042\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of individual O-fucose sites for NOTCH2 incompletely defined\", \"DTX3 regulation primarily shown in cancer cell systems\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Discovery of CARM1 methylation of N2ICD and OTUD1 deubiquitination at K1770 established post-translational control of N2ICD stability and of its binding to MAML1, directly linking modification state to transcriptional output.\",\n      \"evidence\": \"ChIP-seq, site-directed mutagenesis of methylation sites, Co-IP of N2ICD-MAML1; site-specific K1770 deubiquitination assays with conditional knockouts and GVHD model\",\n      \"pmids\": [\"34725461\", \"36574342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between methylation, ubiquitination, and degradation not integrated\", \"Generality across tissues beyond gastric cancer and T cells untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Inducible B-cell experiments established that a single Notch2 signaling event reprograms follicular B cells to marginal-zone identity, demonstrating Notch2 as a binary fate switch in mature cells.\",\n      \"evidence\": \"Inducible Notch2IC expression in mature FoB cells with transcriptome and functional characterization\",\n      \"pmids\": [\"33597542\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological trigger of the switch in vivo not defined here\", \"Stability/reversibility of reprogrammed state untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identifying an endothelial Dll4\\u2013Notch2 axis acting on multinucleated myofibers without cell-cell contact extended Notch2 signaling to muscle mass regulation and a non-classical ligand presentation mode.\",\n      \"evidence\": \"Myofiber conditional knockout and Dll4/Notch2 blocking antibodies across disuse, diabetic atrophy and overload-hypertrophy models\",\n      \"pmids\": [\"35228746\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of contact-independent ligand delivery not resolved\", \"Downstream transcriptional program in myofibers not detailed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defining KLHL6 as an E3 ligase whose evasion by DLBCL mutations stabilizes NOTCH2 established a mutation-driven oncogenic mechanism and connected NOTCH2 stability to RAS signaling.\",\n      \"evidence\": \"CRISPR cullin-RING ligase screen, proteomics, ubiquitination assays, pharmacological rescue with gamma-secretase and AKT inhibitors\",\n      \"pmids\": [\"37235754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking stabilized NOTCH2 to RAS activation not fully mapped\", \"Whether KLHL6 control operates in non-lymphoid tissues unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Mechanistic studies revealed that NOTCH2 output can occur through non-canonical routes, including TNF\\u03b1-driven RBPJ\\u03ba displacement in chondrocytes and Hes1-dependent metabolic reprogramming in osteoclasts, refining how context redirects signaling.\",\n      \"evidence\": \"Notch2 gain-of-function mouse cells with EMSA for RBPJ\\u03ba binding, RNA-seq, scRNA-seq and Hes1 epistasis\",\n      \"pmids\": [\"37865314\", \"38159855\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality of RBPJ\\u03ba displacement mechanism beyond chondrocytes untested\", \"Single-lab models for the gain-of-function allele\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Complementary B-cell and cancer studies refined Notch2 as a quantitative binary fate determinant (GC vs. MZB) and showed Wnt-pathway crosstalk via N2ICD activation of TCF7L2 transcription without direct protein interaction.\",\n      \"evidence\": \"Conditional ablation and constitutive activation in B cells with mathematical modeling; organoid screening, ADAM10 modulation, and negative N2ICD-TCF7L2 Co-IP with transcriptional assays\",\n      \"pmids\": [\"38438375\", \"39601111\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Indirect mechanism of TCF7L2 transcriptional activation not fully resolved\", \"Thresholds setting the GC vs. MZB decision in physiological immunization incompletely quantified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the layered control of N2ICD dose and duration\\u2014glycosylation, methylation, ubiquitination/deubiquitination, and tissue-specific gamma-secretase\\u2014integrates to produce opposite (tumor-suppressive vs. oncogenic) outcomes in different cell types remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified quantitative model linking modification state to fate output\", \"Determinants of cell-type-specific tumor suppressor vs. oncogene behavior undefined\", \"Crosstalk hierarchy among the post-translational regulators not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 5, 29, 38, 41]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [11, 14, 24, 27]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 17, 38]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [11, 15, 34]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 29, 30]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 14, 24]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [7, 9, 16, 27]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 28, 30, 32, 35, 40]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [10, 13, 34]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [25, 29, 30, 34]}\n    ],\n    \"complexes\": [\n      \"N2ICD-RBPJk-MAML1 transcriptional activation complex\"\n    ],\n    \"partners\": [\n      \"RBPJ\",\n      \"MAML1\",\n      \"ADAM10\",\n      \"CARM1\",\n      \"KLHL6\",\n      \"DTX3\",\n      \"OTUD1\",\n      \"TRAF6\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}